Caris Detect combines whole genome sequencing and AI; ACHIEVE 1 study showed 60.3% sensitivity for stage I-II cancers including colorectal. (Fierce Biotech)
New blood test achieves 60% sensitivity for early-stage cancers
The CRC Digest
The CRC Digest
Caris Detect combines whole genome sequencing and AI; ACHIEVE 1 study showed 60.3% sensitivity for stage I-II cancers including colorectal. (Fierce Biotech)